Clinical Trial Update: Evidence of Haloperidol Absorption After Topical Administration [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating the absorption of topical haloperidol for nausea and vomiting has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Vomiting

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Eric E. Prommer | Conditions: Nausea, Vomiting | EARLY_Phase 1 | Status: WITHDRAWN